Home » Stocks » TELA Bio

TELA Bio, Inc. (TELA)

Stock Price: $13.92 USD 0.27 (1.98%)
Updated Jul 6, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 200.61M
Revenue (ttm) 15.87M
Net Income (ttm) n/a
Shares Out 11.41M
EPS (ttm) -6.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 6, 2020
Last Price $13.92
Previous Close $13.65
Change ($) 0.27
Change (%) 1.98%
Day's Open 14.05
Day's Range 13.87 - 14.34
Day's Volume 83,057
52-Week Range 5.25 - 23.55

More Stats

Market Cap 200.61M
Enterprise Value 184.29M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 11.41M
Float 2.68M
EPS (basic) n/a
EPS (diluted) -6.48
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 92,379
Short Ratio 3.75
Short % of Float 1.77%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 12.64
PB Ratio 8.60
Revenue 15.87M
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash 16.32M
Net Cash / Share 1.13
Gross Margin 60.36%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -29.95%
ROE -450.30%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$18.25*
(31.11% upside)
Low
14.0
Current: 13.92
High
24.0
Target: 18.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017
Revenue15.458.274.25
Revenue Growth86.68%94.91%-
Gross Profit9.272.942.53
Operating Income-19.16-17.78-16.92
Net Income-22.43-21.09-21.33
Shares Outstanding1.770.290.29
Earnings Per Share-17.10-101.41-93.26
Operating Cash Flow-25.52-19.92-16.37
Capital Expenditures-0.20-0.06-0.10
Free Cash Flow-25.72-19.98-16.47
Cash & Equivalents54.5917.2811.37
Total Debt30.2429.734.52
Net Cash / Debt24.34-12.466.86
Assets67.9227.2315.53
Liabilities36.9640.9412.35
Book Value30.96-138-108
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TELA Bio, Inc.
Country United States
Employees 89
CEO Antony Koblish

Stock Information

Ticker Symbol TELA
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: TELA

Description

TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.